Close

Cempra (CEMP) Announces Receipt of Positive FDA AdCom Vote on Solithromycin in CABP

Go back to Cempra (CEMP) Announces Receipt of Positive FDA AdCom Vote on Solithromycin in CABP

Cempra (CEMP) Shares Halted Ahead of FDA AdCom on Solithromycin as CABP Treatment

November 4, 2016 7:06 AM EDT

Cempra, Inc. (Nasdaq: CEMP) announced that NASDAQ has halted trading of the company's common... More